ImmunityBio stock climbs 10% on FDA RMAT designation ImmunityBio stock climbs 10% on FDA RMAT designation Post ContentibrxRead More You might also be interested in reading Nxu shareholders approve merger with Verde Bioresins. February 28, 2025 In Mainstream ← Previous post Next post →